MERCK & CO "MOST ADMIRED" US FIRM
US drugmaker Merck & Co is the most admired corporation in the USA for the seventh consecutive year, according to Fortune magazine's annual survey of corporate reputations. No other pharmaceutical company figures in the overall top ten.
The Fortune study is based on the opinions of some 8,000 senior executives, outside directors and security analysts in 32 industries, based on eight key parameters: quality of management; financial soundness; quality of products and services; ability to attract, develop and keep talented people; use of corporate assets; value as long-term investments; innovativeness; and the company's community and environmental responsibility.
Based on financial performance alone, Merck still heads the Fortune list, but here Bristol-Myers Squibb comes in at number seven, American Home Products at eight and Abbott Labs at number ten.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze